Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Sambhaav Media Ltd, Jindal Worldwide Ltd, Lloyds Metals & Energy Ltd and Nagarjuna Fertilizers & Chemicals Ltd are among the other losers in the BSE’s ‘B’ group today, 21 April 2022.

Earum Pharmaceuticals Ltd leads losers in ‘B’ group

Earum Pharmaceuticals reports standalone net loss of Rs 0.72 crore in the March 2022 quarter

Earum Pharmaceuticals reports standalone net profit of Rs 0.95 crore in the December 2021 quarter

Manaksia Aluminium Company Ltd, Om Infra Ltd, Earum Pharmaceuticals Ltd and 3i Infotech Ltd are among the other losers in the BSE’s ‘B’ group today, 23 December 2021.

Cyber Media (India) Ltd leads losers in ‘B’ group

Earum Pharmaceuticals was locked in an upper-circuit of 5% at Rs 70.35 after the company fixed Saturday, 18 December 2021 as the record date for determining eligibility of members for the purpose of sub-division of the equity shares of the company.

Earum Pharmaceuticals hits the roof ahead of record date for stock split

Earum Pharmaceuticals reports standalone net profit of Rs 5.40 crore in the September 2021 quarter

Nagreeka Capital & Infrastructure Ltd, Earum Pharmaceuticals Ltd, Creative Eye Ltd and Rollatainers Ltd are among the other losers in the BSE’s ‘B’ group today, 04 October 2021.

TCI Finance Ltd leads losers in ‘B’ group

Earum Pharmaceuticals is an India-based manufacturer and supplier of pharmaceuticals.

Earum Pharmaceuticals board to consider stock split on Oct 08; Stock trades lower

Board of Earum Pharmaceuticals approves bonus issue of 1:1

Earum Pharmaceuticals to consider bonus issue

Earum Pharmaceuticals is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs etc

Earum Pharmaceuticals Ltd

With a market cap of ₹31 cr, stock is ranked 2,796

Earum Pharmaceuticals Ltd

Earum Pharmaceuticals Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Earum Pharmaceuticals Ltd leads losers in ‘B’ group

Earum Pharmaceuticals reports standalone net loss of Rs 0.72 crore in the March 2022 quarter

Earum Pharmaceuticals reports standalone net profit of Rs 0.95 crore in the December 2021 quarter

Cyber Media (India) Ltd leads losers in ‘B’ group

Earum Pharmaceuticals hits the roof ahead of record date for stock split

Earum Pharmaceuticals reports standalone net profit of Rs 5.40 crore in the September 2021 quarter

TCI Finance Ltd leads losers in ‘B’ group

Earum Pharmaceuticals Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Earum Pharmaceuticals Ltd leads losers in ‘B’ group

Earum Pharmaceuticals reports standalone net loss of Rs 0.72 crore in the March 2022 quarter

Earum Pharmaceuticals reports standalone net profit of Rs 0.95 crore in the December 2021 quarter

Cyber Media (India) Ltd leads losers in ‘B’ group

Earum Pharmaceuticals hits the roof ahead of record date for stock split

Earum Pharmaceuticals reports standalone net profit of Rs 5.40 crore in the September 2021 quarter

TCI Finance Ltd leads losers in ‘B’ group

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock